Virus outbreak: news and analysis as of January 7, 2021

Photographer: Octavio Jones / Getty Images

We follow the latest news on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

The AstraZeneca Plc-Oxford University vaccine showed limited efficacy against mild disease caused by the South African variant of Covid-19, according to early data in a small phase trial.

New cases in the US continued to signal a downward trend. While the number of deaths remains high, the average daily increase in the number of infections has decreased by 20% from the previous week. New cases in Brazil have fallen for the third week in a row.

China contained a northern eruption, with just one new infection in Jilin province. Australia has expanded testing for quarantined travelers to prevent the virus from entering the community. Zimbabwe is in talks with Russia to buy a stockpile of the Sputnik V Covid-19 vaccine, state media reported Sunday.

Main Developments:

Subscribe to one daily update on the virus by Bloomberg’s Prognosis team here. Click CVID on the terminal for general data on cases and deaths.

covid-vaccine-tracker-worldwide-distribution-world-vaccination-inline

Zimbabwe in talks with Russia about vaccination: (6:35 PM HK)

Zimbabwe is in talks with Russia to buy a stockpile of the Sputnik V Covid-19 vaccine, state media reported Sunday. “We are working on the modalities,” Anastasia Samoylenko, an official from the Russian embassy, ​​told the Sunday Mail. No further details were provided on the quantities of vaccines and when delivery can begin for the South African nation.

On Thursday, President Emmerson Mnangagwa said the country, which has been under strict exclusion since January 5, would now introduce vaccines as “a second preventive measure.”

Hong Kong worries about Chinese New Year (6:10 pm HK)

Hong Kong health officials expressed concern over large family gatherings and festive public markets ahead of the Lunar New Year festival in the coming days, as it reported 27 new cases of coronavirus on Sunday. “It’s a concern for us because with all the festivities we know people want to get together, meet with relatives or spend time at New Year’s fairs,” said Chuang Shuk-kwan, the head of the communicable diseases division of the health department. told reporters.

UK government is considering vaccinating some at work (17:45 HK)

British ministers are considering proposals to vaccinate millions of people on the front lines – including teachers and emergency services – under 50 at work from the spring, the Telegraph reported, citing unidentified government sources.

Under the plan, delivery drivers, workers at supermarkets and food processing factories would jump forward in the queue for jobs, the paper said. Prison staff, police officers, and even jurors can also be prioritized.

French Industry Minister ‘Agnostic’ on Russian vaccine (16:45 HK)

French Industry Minister Agnes Pannier-Runacher said she is “agnostic” about the Russian shot, adding that any jab “that is ready and presents the safety and efficacy conditions is welcome in Europe.” During an interview on France Info TV on Sunday, Pannier-Runacher also said that the virus circulation in France is relatively low compared to other European countries.

“We have some cases that have stabilized, on a high plateau, but it has stabilized, so we’re lucky we don’t have to go into a lockdown again.” France also plans to stick to its goal of vaccinating its “vulnerable” population, which represents about 15 million, by June, she added.

Indonesia approves Sinovac vaccine for the elderly (12:50 hrs HK)

According to the Ministry of Health, Indonesia has the Covid-19 vaccine from China’s Sinovac Biotech Ltd. approved for use in the elderly and can begin vaccinations between March and April.

Indonesia began its massive inoculation campaign on January 13 with a Sinovac vaccine. More than 777,000 people have received their first shot, and about 137,000 have a second, official data shows. The government plans to vaccinate 181.5 million people by March 2022.

Malaysia to house migrant workers in hotels (11:45 am HK)

The Malaysian government has launched a plan to temporarily house migrant workers in near-empty hotels across the country to address the worsening spread of Covid-19 cases due to workplace clusters.

The program will indirectly help hotel operators affected by the pandemic, the tourism ministry said. Overcrowded conditions in worker dormitories have been a major source of infection, fueled record cases and strained the Malaysian health system. According to the Ministry of Human Resources, the country has more than 1.5 million documented migrant workers, 91% of whom live in accommodation that does not meet minimum housing standards.

Thailand’s Covax Reluctance (9:35 am HK)

The Thai Government will not purchase Covid-19 vaccines through the World Health Organization-sponsored Covax program for the time being because the conditions are too strict. The move could put the country in danger of getting delayed vaccines at higher prices.

According to the program, Thailand would be charged extra for booking and would have restrictions on producers and delivery time. Covax also requires a minimum purchase of 10% of a country’s population for a quick order with terms and costs, said Nakorn Premsri, director of the National Vaccine Institute in Thailand.

China Outbreak Reined In (8:42 am HK)

China reported just one new local case in Jilin province as the country is controlling the resurgence of the coronavirus in the northern regions. The number of open cases in the country totaled 1,176 yesterday, the National Health Commission said.

Australian state tightens quarantine tests (7:48 AM HK)

Australia’s most densely populated state has tightened quarantine testing rules for Covid-19 to prevent the virus from entering the community. Returning foreign travelers in New South Wales should now be tested two days after completing 14-day hotel quarantines, NSW Health said in a statement.

Kentucky passes 4,000 dead (7:02 am HK)

.Source